Eighty patients undergoing coronary artery surgery were randomly allocated to receive either 0, 2, 5, 10 or 15 pg/kg of fentanyl with induction of anaesthesia. Heart rate and blood pressure were measured before induction, after induction, and after intubation. The effects offentanyl dose on both heart rate and mean arterial pressure (MAP) were evaluated in terms of both the mean and group responses. At all doses offentanyl, mean heart rate increased after induction and rose further on intubation. The mean increase after induction was minimal at doses of 5 pg/kg and greater. The increase in heart rate after intubation was more difficult to block but with afentanyl dose of 15 pg/kg, 87% of patients had heart rates below 100 bpm. As a group, the percentage of patients in whom the postintubation heart rate remained below 100 bpm increased progressively with the fentanyl dose. In contrast, mean MAP fell at all dose levels after induction, the mean fall being about 30 mmHg at 5 pg/kg and greater. Mean MAP exceeded pre-induction values after intubation with 0 and 2 pg/kg, and progressive attenuation of the MAP rise was found as the dose offentanyl increased. The percentage of patients who did not exceed their preinduction MAP rose progressively with increasing dose of fentanyl with an ED 5 of 3.7 pg/kg. If a minimal fall in mean MAP after inJuction with no rise above preinduction MAP is the sole criterion, afentany! dose of about 3 pg/kg is recommended. Ifheart rate is to be kept below 100 bpm, a dose of at least 10 pg/kg should be used. However, this dose or greater will cause the MAP to fall in some patients to less than 70 mmHg. The choice of the most appropriate dose depends on the anaesthetist's view of the relative importance of avoiding tachycardia or hypotension in the patient with coronary artery disease.
techniques have been employed to attenuate these sympathetic responses, a recent popular method has been to use substantial doses of narcotic, particularly fentanyl, intravenously in the induction. High doses of fentanyl of 30 Jl.g1kg (or more) are effective in blocking the sympathetic response to intubation. 34 However, such large doses often cause marked respiratory depression and are only suitable if ventilatory support is maintained for many hours postoperatively. Alternatively, with induction of anaesthesia, low doses of fentanyl ranging from 2 ~glkg to 8 ~g/kg have been used in conjunction with thiopentone to suppress the sympathetic response to intubation. 5 . 7 The purpose of this study was to determine the optimal dose of fentanyl, in a th iop en tone-fen tanyl-pancuroni urn induction sequence, which would suppress the hypertensive and tachycardic response to laryngoscopy and intubation in patients undergoing coronary artery surgery.
MATERIALS AND METHODS
Eighty patients about to have coronary artery vein graft surgery were studied. Only those patients considered to have 'good' left ventricular function and who were sinus rhythm were selected. None had symptoms or a history of congestive heart failure or had suffered an infarct within eight weeks of the operation. None had left ventricular dyskinesia or disease of the left main coronary artery. All patients had left ventricular enddiastolic pressures of less than 18 mmHg on cardiac catheterisation. They were randomly allocated to one offive groups to receive either 0, 2, 5, 10 or 15 ~g/kg of fentanyl following a 'sleep' dose of thiopentone and preceding 0.1 mg/kg of pancuronium. In accordance with the general policy of the Cardio-thoracic Unit all cardiac drugs, except glyceryl trinitrate: were ceased for 48 hours before surgery. Patients were premedicated with papavere~um 0.3 mg/kg and metoclopramide, 10 mg mtramuscularly, one hour before surgery.
On arrival in the operating theatre, the pulse was timed for at least 30 seconds and a preinduction blood pressure was recorded by auscultation (diastolic reading as Korotkoff Phase V) using an anaeroid sphygmomanometer previously checked at zero and 100 mmHg against a mercury column. After preoxygenation for one minute, thiopentone was injected slowly until the disappearance of the eyelash reflex occurred and this was followed by the selected dose of fentanyl and the pancuronium. While the patient was being ventilated with N20/02 6:3, an arterial line was established and direct pressure recording commenced. Laryngoscopy and intubation were accomplished within 4 minutes of induction and blood pressure recording continued for 2 minutes or more after this. Heart rate was calculated by timing at least 10 beats on the arterial trace. The same beats were used for the blood pressure measurement. The post induction mean arterial blood pressure (MAP) was calculated over the respiratory cycle before intubation. Similarly after breathing had been established on the ventilator, at approximately one minute after intubation, mean blood pressures were calculated in the same way. Mean blood pressure was estimated in the conventional way from the diastolic pressure plus one-third of the pulse pressure. Because logistical requirements prevented us from obtaining the preinduction pressure measurement directly, 10 patients had their systolic and diastolic pressures measured at the end of the procedure by both methods. The mean difference was 4.50 mmHg (SD 5.63) greater for MAP using the auscultatory technique. This difference was applied to the preinduction mean pressures. The variability was also increased by the observed variability. 8 The changes in the heart rate and mean arterial blood pressure between preinduction, postinduction and post intubation values were compared using analysis of variance (ANOV AR) or Student's t tests as appropriate.
RESULTS
The number of subjects, their mean ages, body weight, thiopentone dose, initial heart rate and MAP values are given in Table 1 . Because of the randomisation process the groups are not exactly equal numbers. The non-fentanyl group was terminated after seven subjects, as two of the seven had ectopic beats and it was felt patients were being subjected to an unacceptable risk. None of the patients in this group suffered any harm from the induction episode.
Each group, including the zero dose group, was comparable in terms of age, weight, thiopentone dose, preinduction MAP, heart rate (ANOVAR F475 = 1.56, for each treatment group at each time. For the zero fentanyl (control) group, there are large and significant rises in mean heart rate both at the postinduction and at the postintubation stages as compared with the preinduction value. The postintubation rise with 2 ~glkg fentanyl is also significant. Even though 5 ~glkg fentanyl prevented a rise in mean heart rate with induction, a rise in the mean still occurred after intubation but this just fails to be of statistical significance (t = 2.0, P = 0.06). However, 1 0 ~glkg of fentanyl prevented a postintubation tachycardia. The dose/response curve appears to plateau beyond 1 0 ~glkg fentanyl and the effect of a dose of 15 ~glkg is similar in magnitude. Alternatively, the data can be examined as group dose/response curves. Heart rate dose response curves are shown in Figure 2 . Deriving a dose response curve with respect to the criterion that the postintubation heart rate does not exceed the preinduction heart rate shows a maximum of 40% success at a fentanyl dose of 1 0 ~glkg. If a simpler (14) 81 (13) criterion is used, i.e. a heart rate remaining below 100 bpm postintubation, an enhanced success rate is seen with increasing doses of fentanyl and the EDso is 3.2 Ilglkg. As the maximum success rate was only 87%, an estimate of an ED95 was not made. . The mean values of MAP are shown III Figure 3 Table 1 . The mean values of all groups show a fall after induction which is statistically significant t=3.2, P=0.02, t=8.0, P<O.OOI, t=9.7, P<O.OOI, t=8.8, P<O.OOI, t=8.3, P<O.OOI for 0,2,5,10,15 ~g/kg fentanyl respectively. After intubation the rise above the preinduction level is significant for 0 ~g/kg (t = 2.7, P= 0.04). It is not significant for 2 ~g/kg (P = 0.3). The low MAP below preinduction levels with 5 ~g, 10).!g and 15 ~g/kg after intubation is also statistically different from the preinduction MAP t = 4.4, P = 0.002, t = 5.8, P < 0.001 and t = 7.8, P < 0.001 respectively). fall in pressure after induction does not increase beyond 5 Ilglkg of fentanyl, i.e. a decrease of about 30% in MAP occurs with this dose and greater doses. On intubation, the zero fentanyl group shows a significant rise in MAP of 17% above the preinduction value (2 of 7 patients showed ventricular ectopics). With 2 Ilglkg offentanyl there was a mean rise in MAP of 7% above the preinduction level. With larger doses of fentanyl, although rises in mean MAP occurred, the MAP remained less than the preinduction pressure, the effect again plateauing beyond the 10 Ilglkg fentanyl dose. When dose/response curves for the MAP are examined, the exact criteria are less important (Figure 4 ). The criterion of MAP postintubation not exceeding the preinduction levels and MAP not exceeding 100 mmHg give similar EDsos at 3.7 and 3.5 Ilglkg and ED9SS at 12.4 and 13.6 Ilglkg respectively. However, at 5 Ilglkg fentanyl and above there is a risk of excessive hypotension (MAP < 70 mmHg). For 5, 10 and 15 Ilglkg doses, the percentage of cases with hypotension were 10.5%, 45% and 27% respectively. If the combined criteria of heart rate remaining below 100 bpm and MAP not exceeding 100 mmHg are used, the ED 50 is about 5 ~g1kg ( Figure 5 ). An estimate of ED95 was not made because the maximal success rate which occurred with 15 ~g1kg was only 87%. These combined criteria show a lower success rate at any given dose but still increasing success with increasing dose.
DISCUSSION
This study examines heart rate and blood pressure changes during induction of anaesthesia and intubation using a thiopentone, fentanyl, pancuronium, N20/02 sequence. It is well recognised that heart rate increases after induction and there are further increases with laryngoscopy and intubation. Similarly, the fall in blood pressure after induction and the rise with intubation is familiar. Although fentanyl has frequently been studied as a means of blocking these effects, information about the dose/response curve is sparse. For this reason, the present study aimed to obtain this information on fentanyl for stable cardiac patients managed with a conventional anaesthetic technique.
Anaesthesia and Intensh"p Care. Vol. /6. No. 4, November. 1988 Some of the heart rate and blood pressure changes which occurred with induction were caused by drugs other than fentanyl, i.e. thiopentone, pancuronium or nitrous oxide. However, these were applied similarly in all groups and the mean change which this sequence alone causes can be seen in the zero fentanyl group. Only the fentanyl dose was varied and so the differences in heart rate and blood pressure between the groups are the result of the differences in fentanyl dose. It is probable that some interactions have occurred. For example, the initial induction caused a fall in blood pressure and tachycardia without fentanyl, probably mainly by vasodilatation. Fentanyl may have increased this vasodilatation but by 5 ~g/kg the dilatation seems to have been maximal and this would explain the plateau with 10 and 15 ~g1kg. Such synergism may not occur with other drug sequences and a different degree of HR and MAP response might occur with other drugs such as if vecuronium were used rather than pancuronium. Increases in heart rate after induction and after intubation were both reduced by fentanyl. The mean rise after induction was blocked by fentanyl in doses of 5, 10 and 15 ~g1kg. However, the mean heart rate rise after intubation was more difficult to block and was never completely abolished. There appeared to be little further attenuation with 15 ~g1kg than occurred with the 1 0 ~g1kg fentanyl dose. Thus the lowest dose of fentanyl to achieve a maximal attenuation of the rise in heart rate with induction and intubation appears to be 1 0 ~g1kg.
Blood pressure fell after induction even without fentanyl. However, the addition of fentanyl increased the fall in blood pressure after induction, although this effect was not more marked with doses above 5 ~g1kg. In contrast, suppression of the rise in blood pressure was less easily achieved and the rise was not completely abolished until 15 ~g1kg fentanyl. However, with doses of 5 ~g1kg or more, the rise in MAP after intubation did not exceed the initial blood pressure and the 'neutral' dose of fentanyl to prevent MAP rising above the preinduction level is about 3 ~g1kg (Figure 3) .
A similar situation is found for dose/ response curves. If an adequate response is deemed to be a heart rate not exceeding preinduction levels, the best response occurs at 1 0 ~g/kg. However, only a 40% response was achieved as increasing the dose of fentanyl appears to also cause an increase in pulse rate. On the other hand, suppression of the heart rate to below 100 bpm is increasingly successful with increasing doses of fentanyl. In contrast, choosing between the two MAP criteria appears to be less important as both preinduction and absolute (less than 100 mmHg) criteria have similar success and dose response lines (Figure 4 ). Combined absolute heart rate and MAP criteria increase the ED50 of the dose response curve to 5 ~g/kg, but even 15 ~g/kg achieves only an ED87 level. If avoiding excessive hypotension is important then it must be appreciated that 5 ~g/kg and greater will incur some risk of MAP below 70 mmHg.
From these results it is clear that the 'optimal' dose of fentanyl will depend substantially on what the anaesthetist believes is the most important cardiovascular parameter to attenuate and what is the most appropriate degree of control.
In patients with coronary artery disease, the aim of the anaesthetist is to maintain oxygen balance in the myocardium by not decreasing supply or increasing demand. Decreases in supply may occur because of hypotension, and increases in demand may occur due to tachycardia or hypertension. It has been stated by Merin 9 ,IO that myocardial oxygen consumption should be kept as close as possible to the unanaesthetised angina-free value, while maintaining coronary perfusion pressure. However, others have accepted that a 'low pressure-low demand' anaesthetic technique where the decrease in supply is matched by a decrease in demand best preserves myocardial oxygenation. 11 ,12 Moffitt 13 and Foex 14 both postulated in 1986 that if myocardial oxygen consumption is kept low by a heart rate of around 70/min and a MAP of around 70-75 mmHg, myocardial oxygenation is unlikely to suffer in patients with coronary artery disease. So it seems that some authorities accept a lower MAP if tachycardia is avoided.
Our study suggests that 3 ~g/kg of fentanyl in a thiopentone-pancuronium induction sequence prevents the MAP from exceeding the preinduction values after intubation. However, this dose would not prevent a rise in heart rate which would require about 1 0 ~g/kg. Giving a dose of fentanyl 1 0 ~g/kg means that one has to expect a fall of about 30% in MAP on induction (Figure 3 ).
Can the goal of matching anaesthetic depth to intensity of applied stimulus, in order not to disturb myocardial oxygen balance be attained by the induction sequence of thiopentone-fentanyl-pancuronium? If, in the anaesthetist's opinion, heart rate control is considered to be the major requirement for cardiac protection, 1 0 ~g/kg of fentanyl would be the preferred dose to achieve this aim but a fall in pressure after induction must be accepted. If preservation of blood pressure is considered to be necessary, a dose of about 3 ~g/kg would minimise the post induction fall but not allow the blood pressure after intubation to exceed the awake level. However, only about 50% of patients will avoid a tachycardia. Alternatively, accepting a combined absolute HR and MAP criteria suggests an ED of 5 ~g/kg, a dose which incurs only a 106~ risk of hypotension. It may be advisable to look critically in each patient at the relative contributions of heart rate and hyper-and hypotension in causing angina. Patients who seem to be more susceptible to tachycardia or to hypertensive surges may be better managed with a dose of 10 ~g/kg, whereas patients who have a greater susceptibility to a low perfusion pressure may do better with a fentanyl dose of about 3 ~g/kg. If the patient has symptoms affected by both tachycardia and low perfusion parameters, a dose of 5 ~g/kg may be preferred.
